MTZ Add to watchlist $365.07 0.82 (-0.22%) Last updated: Apr 16, 2026 02:39
52-Week Range
$365.07
$109.68 $365.07 $371.62

Fundamentals Overview

MasTec, Inc. is near the high of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 72 PEG 0.5 P/B 8.72 P/S 2.01

Intrinsic value (DCF)

-78.8% downside vs price

Profitability

Net margin 2.8%

Risk (Beta)

1.8 — higher vol

Earnings & growth

EPS $5.07 Rev -0.7% Profit -11.2% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 59% confidence Risk: High Volatility — Beta 1.8. Consider smaller position size due to higher beta.

Supporting (Buy):

Analyst grade: B- · 3M vs S&P 500: +62.5% · 3M vs Industrials sector: +58.3%

Pressures (Sell):

DCF 78.8% downside vs price · Beta 1.8 (elevated)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$28.80B
P/E (TTM)
72.02
EPS (TTM)
$5.07
Dividend Yield
N/A
52-Week Range
$109.68 - $371.62
Volume vs Avg
N/A
Beta
1.8

About

MasTec, Inc., an infrastructure construction company, provides engineering, building, installation, maintenance, and upgrade services for communications, energy, utility, and other infrastructure primarily in the United States and Canada. It operates through Communications, Clean Energy and Infrastructure, Oil and Gas, Power Delivery, and Other segments. The company builds underground and overhead distribution systems, including trenches, conduits, cell towers, cable, and power lines, which prov...
Sector: Industrials
Headquarters: US
Employees: 32,000
IPO Date: Feb 1973
Beta: 1.8 (More volatile than market)

Ratings & Grades at a Glance

Overall rating: B-. Recent institutional grades: mixed. Current institutional positions: Buy: 16, Neutral: 1, Outperform: 5, Overweight: 8.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $77.50; current price is $365.07. That’s a -78.8% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 72.02
DCF value (model) $77.50 (-78.8% vs price)
PEG (TTM) 0.5
P/B (TTM) 8.72
P/S (TTM) 2.01
P/FCF (TTM) 138.73
Liquidity & enterprise
Current Ratio (TTM) 1.32
Quick Ratio (TTM) 1.29
Cash Ratio (TTM) 0.12
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 2.79%
Gross margin (TTM) 11.76%
Operating margin (TTM) 5.3%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for MTZ.

Analyst Sentiment at a Glance

B- Sentiment Mixed
Buy 16Neutral 1Outperform 5Overweight 8
1 upgrade, 1 downgrade
Price Target Consensus
Current $365.07
Median $326.00
Consensus $310.29
Low consensus $260.00
High consensus $362.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
UBS maintain Buy Buy 2026-04-13
Barclays maintain Overweight Overweight 2026-03-31
Jefferies maintain Buy Buy 2026-03-13
Mizuho maintain Outperform Outperform 2026-03-03
Cantor Fitzgerald maintain Overweight Overweight 2026-03-02
Baird maintain Outperform Outperform 2026-03-02
DA Davidson maintain Buy Buy 2026-03-02
Citigroup maintain Buy Buy 2026-03-02
Keybanc maintain Overweight Overweight 2026-03-02
Truist Securities maintain Buy Buy 2026-03-02
Citigroup maintain Buy Buy 2026-01-26
Barclays maintain Overweight Overweight 2026-01-23
Truist Securities maintain Buy Buy 2025-12-18
Stifel maintain Buy Buy 2025-12-16
Baird maintain Outperform Outperform 2025-11-03
Truist Securities maintain Buy Buy 2025-11-03
Keybanc maintain Overweight Overweight 2025-11-03
Mizuho maintain Outperform Outperform 2025-10-28
Keybanc maintain Overweight Overweight 2025-10-20
Barclays maintain Overweight Overweight 2025-10-20
JP Morgan maintain Overweight Overweight 2025-10-16
Guggenheim downgrade Buy Neutral 2025-10-15
Stifel maintain Buy Buy 2025-10-09
Truist Securities maintain Buy Buy 2025-10-08
Citigroup maintain Buy Buy 2025-10-03
UBS maintain Buy Buy 2025-10-01
Jefferies maintain Buy Buy 2025-10-01
Roth Capital maintain Buy Buy 2025-09-25
Wolfe Research upgrade Peer Perform Outperform 2025-09-17
Goldman Sachs maintain Buy Buy 2025-08-07